

English
-
-
Dengue in the Midst of COVID-19 Pandemic
ADVA14 minutes -
What is the diagnosis? - Challenging Pediatric ID Cases in Dengue Endemic Regions
WSPID59 minutes -
Emerging Issues in Dengue Control
Takeda -
Experience of a tertiary hospital in Singapore managing a dual outbreak of COVID and dengue
Takeda2 minutes -
Case report: Acute vision loss in a young returning traveler with dengue fever
Takeda2 minutes -
Covid-19 and dengue: Double punches for dengue-endemic countries in Asia
Takeda2 minutes -
First autochthonous dengue outbreak in Italy, August 2020
Takeda2 minutes -
Insecticide resistance in dengue vectors from hotspots in Selangor, Malaysia
Takeda2 minutes -
Dengue is the most common non-malarial febrile illness in Southern Asia and Southeastern Asia
Takeda2 minutes -
When fever is not malaria in Latin America
Takeda2 minutes -
Similarities and differences between 'cytokine storms’ in acute dengue and COVID-19
Takeda2 minutes -
Dengue: Not Just 1 Virus, Not Just 1 Infection
Medscape15 minutes -
Surveillance and Reporting
Takeda5 minutes -
Antibody Levels over Time
Takeda2 minutes -
Laboratory diagnostic tests
Takeda -
Differential diagnosis
Takeda1 minutes -
Dengue disease states
Takeda4 minutes -
Burden of Dengue
Takeda38 minutes -
Challenges in the management and diagnosis of Zika, Dengue and Chikungunya
Takeda42 minutes -
Immune response to dengue virus
Takeda4 minutes -
Dengue virus and pathobiology
Takeda1 minutes -
Clinical diagnosis and management of dengue
PAHO -
Dengue Clinical Case Management
CDC -
The global trends and regional differences in incidence of dengue infection from 1990 to 2019: An analysis from the Global Burden of Disease Study 2019
Takeda2 minutes -
NS1 and its potential association with severe dengue
Takeda3 minutes -
Dengue - unanswered scientific questions
Takeda11 minutes -
Antibody-dependent enhancement of severe dengue disease in humans
Takeda2 minutes -
Dengue: diagnosis and treatment updates
ISID62 minutes -
Resources for patient support
Takeda3 minutes -
Causes of fever in returning travelers: A European multicenter prospective cohort study
Takeda2 minutes -
Dengue diagnosis: unique challenges in a time of a pandemic
Medscape15 minutes -
Dengue serotypes
Takeda4 minutes -
Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes
Takeda2 minutes -
A fatal case report of antibody-dependent enhancement of dengue virus type 1 following remote Zika virus infection
Takeda2 minutes -
Coagulation abnormalities in Dengue fever infection: A systematic review and meta-analysis
Takeda2 minutes -
Distinct Dengue Epidemiology and Viral Characteristics in Indonesia
ADVA25 minutes -
Dengue Virus Life Cycle
HHMI BioInteractive4 minutes -
Zika and dengue but not chikungunya are associated with Guillain–Barré syndrome in Mexico: A case-control study
Takeda2 minutes
Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda
© Copyright 2025 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2023